SCHEMBL7658593

SCHEMBL7658593

O=C(NC(O)CCO)c1cnc(C(=O)NC(O)CCO)cn1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 2/20 0.38
MME P08473 1/20 0.37
CCR1 P32246 1/20 0.36
CNR1 P21554 3/20 0.35
HPGD P15428 2/20 0.34
LMNA P02545 1/20 0.34
PSMB5 P28074 2/20 0.33
PSMB11 A5LHX3 1/20 0.33
PSMA7 O14818 1/20 0.33
PSMB1 P20618 1/20 0.33
PSMA1 P25786 1/20 0.33
PSMA2 P25787 1/20 0.33
PSMA3 P25788 1/20 0.33
PSMA4 P25789 1/20 0.33
PSMB8 P28062 1/20 0.33
PSMB9 P28065 1/20 0.33
PSMA5 P28066 1/20 0.33
PSMB4 P28070 1/20 0.33
PSMB6 P28072 1/20 0.33
LONP1 P36776 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7657510 0.84 ALDH1A1 (0.45) MMELMNAALDH1A1POLBNPC1
SCHEMBL7650766 0.82 CTSA (0.35) CNR2CCR1CNR1HPGDLMNA
SCHEMBL7658603 0.79 MME (0.39) CNR2MMECNR1PSMB5PSMB11
SCHEMBL7659871 0.79 LMNA (0.45) CNR2HPGDLMNAALDH1A1POLB
SCHEMBL7653658 0.75 KDM4E (0.44) HPGDALDH1A1POLBATML3MBTL1
SCHEMBL7105347 0.75 CNR1 (0.46) CNR2MMECNR1
SCHEMBL7104649 0.73 CNR1 (0.44) CNR2MMECCR1CNR1PSMB5
SCHEMBL18130942 0.73 LMNA (0.45) CNR2CNR1LMNANPC1RAB9A
SCHEMBL18130920 0.73 LMNA (0.45) CNR2CNR1LMNANPC1RAB9A
SCHEMBL18130968 0.73 LMNA (0.45) CNR2CNR1LMNANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6399613-B1 N,N'-BIS(2-HYDROXYETHYL)PYRAZINE-2,5- OR -2,6-DICARBOXAMIDE; DIABETES AVENTIS PHARMA S.A. (FR) 2002-06-04 US claimed
US-6399613-B1 N,N'-BIS(2-HYDROXYETHYL)PYRAZINE-2,5- OR -2,6-DICARBOXAMIDE; DIABETES AVENTIS PHARMA S.A. (FR) 2002-06-04 US disclosed